Is Your Paper Ready for BMJ Open? The Mega-Journal That Publishes Your Reviewers' Names

The 2.4 impact factor is modest. Let's be honest about that. It's lower than Scientific Reports (3.8) and comparable to PLOS ONE (2.6). But impact factor doesn't tell you whether BMJ Open is the right journal for your paper. What matters is whether your work fits the editorial model and whether the transparency of open peer review is something you want associated with your publication.

BMJ Open doesn't just reveal reviewer names. It publishes the full prepublication history of every accepted paper. That means anyone can read:

• The original submitted manuscript
• Each reviewer's signed report
• The authors' point-by-point responses
• Revised versions of the manuscript
• The editor's decision letters

This is the most transparent peer review process among the major mega-journals, and it has practical consequences.

Reviewers write differently when their names are attached. Research on BMJ's open review model has shown that signed reviews don't become weaker or less critical. They do tend to become more constructive and more carefully reasoned. A reviewer who's going on the record is less likely to write a dismissive one-paragraph rejection and more likely to explain exactly what they think needs to change and why.

Authors can't hide sloppy revisions. Because your responses to reviewers are published, you can't give a vague "we addressed this concern" and hope nobody notices. Readers, including future reviewers of your other work, can see exactly what was raised and exactly how you handled it.

The published review history is a teaching resource. For early-career researchers learning how peer review works, reading through BMJ Open's prepublication histories is genuinely educational. It demystifies a process that most journals keep behind closed doors.

If you're uncomfortable with this level of exposure, that's worth thinking about before you submit. Some authors prefer the anonymity of traditional review. That's fine. But if you believe in transparency, BMJ Open practices what it preaches.

BMJ Open requires strict adherence to reporting guidelines, and this is where many submissions run into trouble. The journal doesn't just recommend these checklists. It requires completed checklists uploaded alongside your manuscript.

Randomized controlled trials: CONSORT checklist and flow diagram. Your trial must be prospectively registered in a public registry (ClinicalTrials.gov, ISRCTN, or equivalent). If you didn't register before enrollment began, BMJ Open will reject the paper.

Observational studies: STROBE checklist. This covers cohort, case-control, and cross-sectional studies. The 22-item checklist forces you to address things like selection criteria, handling of missing data, and sensitivity analyses. Authors who haven't used STROBE before often find gaps in their reporting that they didn't realize were there.

Systematic reviews and meta-analyses: PRISMA 2020 checklist and flow diagram. The updated 27-item checklist requires more detailed reporting than the 2009 version, including specific information about search strategies, risk of bias assessment, and certainty of evidence.

Diagnostic accuracy studies: STARD checklist. Qualitative research: COREQ or SRQR. Quality improvement studies: SQUIRE. The list goes on.

If you're unsure which guideline applies to your study, the EQUATOR Network website has a decision tool. But don't leave this until you're filling out the submission form. Build your manuscript around the relevant checklist from the start. An AI-powered manuscript review can flag missing reporting elements before you submit, saving you a round of desk rejection.

BMJ Open isn't the right journal for every health sciences paper, but it's the right journal for several common scenarios.

You have a well-designed study with modest findings. Your methods are solid, your analysis is appropriate, but the results aren't going to overturn clinical practice. At a selective journal, this paper gets rejected because the editor doesn't think it will generate enough citations. At BMJ Open, it gets evaluated on whether the science is done correctly.

You want your protocol on the record. Publishing your study protocol before data collection is increasingly expected for trials and systematic reviews. BMJ Open is one of the few indexed journals that actively publishes protocols, and having your protocol in PubMed with a DOI adds credibility to the eventual results paper.

You value open peer review. If you believe that peer review should be transparent and accountable, submitting to BMJ Open is a way to put that belief into practice. The published prepublication history also demonstrates to readers that your paper survived genuine scrutiny.

You're running a multi-site or international study. BMJ Open publishes research from all medical disciplines and all geographic regions. The journal's international editorial board and global readership make it a natural fit for research that crosses institutional and national boundaries.

You have a negative result or replication study. Like other mega-journals, BMJ Open doesn't penalize null findings. A negative result from a well-powered study adds real value to the evidence base, and BMJ Open will evaluate it on its merits.

The 27% acceptance rate means about three-quarters of submissions don't make it. Here's what typically goes wrong.

Missing or incomplete reporting checklists. This is the single most preventable reason for rejection at BMJ Open. The journal requires completed checklists for the relevant reporting guideline, and incomplete checklists get papers returned before they reach reviewers. Fill out every item. If an item doesn't apply, say why rather than leaving it blank.

Weak methods sections. If a reviewer can't figure out how you recruited participants, how you defined your exposure and outcome, or how you handled confounders, the paper will get sent back for major revision or rejected outright. Describe your methods as if the reviewer has never worked in your specific sub-field.

Conclusions that go beyond the data. This is universal across journals, but it's worth repeating. If your observational study found an association, don't write your discussion as if you've proven causation. BMJ Open reviewers, whose names are going on the record alongside their reports, are especially careful about calling out overclaiming.

Missing ethics approvals or trial registration. Human subjects research needs ethics committee approval. Clinical trials need prospective registration. BMJ Open checks these at the editorial screening stage, and missing documentation stops your paper cold.

Poor statistical reporting. Report exact p-values, confidence intervals, and effect sizes. Justify your sample size. Explain your handling of missing data. If you're unsure whether your statistical approach will hold up, get a statistician to review it, or run your manuscript through an AI-powered manuscript review to catch common issues before submission.

At 2,163 GBP (approximately $2,750 USD), BMJ Open's APC is higher than PLOS ONE ($2,290) and Scientific Reports ($2,490). That's not trivial, especially for researchers in countries where grant funding is limited.

A few options to offset the cost:

Fee waivers. BMJ offers full APC waivers for corresponding authors based in low-income countries, as classified by the World Bank. Partial waivers are sometimes available on a case-by-case basis.

Institutional agreements. A growing number of universities have Publish and Read agreements with BMJ that cover the APC entirely. Check with your library before you assume you'll be paying out of pocket.

Grant budgets. Most major funders (NIH, Wellcome Trust, UKRI, European Commission) explicitly allow grant funds to cover open access publication charges. If you're writing a grant application, include APC costs in your budget from the start.

The ability to pay does not influence BMJ Open's editorial decisions. The journal states this explicitly, and the open peer review model makes it verifiable: if a paper got accepted despite weak science, the reviewers' names are right there.